🔗 Share this article

The Nobel Prize in Physiology or Medicine has been granted for transformative findings that clarify how the body's defense network targets dangerous infections while sparing the healthy tissues.

Three esteemed scientists—from Japan Shimon Sakaguchi and American scientists Mary Brunkow and Dr. Ramsdell—received this honor.

Their work uncovered specialized "sentinels" within the immune system that remove rogue defense cells capable of attacking the organism.

The findings are now enabling innovative treatments for immune disorders and malignancies.

The laureates will share a prize fund valued at 11m SEK.

Crucial Findings

"The work has been decisive for comprehending how the body's defenses functions and why we do not all develop severe autoimmune diseases," commented the chair of the award panel.

The trio's studies address a fundamental mystery: In what way does the immune system defend us from numerous infections while keeping our own tissues unharmed?

Our body's protection system uses white blood cells that scan for signs of infection, including pathogens and bacteria it has not met before.

These cells employ detectors—known as recognition units—that are produced by chance in countless combinations.

That provides the defense network the ability to combat a wide array of threats, but the randomness of the process unavoidably produces white blood cells that may target the host.

Security Guards of the Body

Researchers earlier knew that some of these harmful defense cells were destroyed in the immune organ—the site where immune cells develop.

This year's Nobel Prize honors the identification of regulatory T-cells—described as the immune system's "security guards"—which patrol the body to neutralize any defenders that assault the body's own tissues.

We know that this process malfunctions in self-attack conditions such as type-1 diabetes, MS, and rheumatoid arthritis.

The prize committee added, "These discoveries have laid the foundation for a novel area of investigation and spurred the development of new treatments, for instance for cancer and immune disorders."

In cancer, T-regs block the body from attacking the growth, so research are aimed at lowering their numbers.

In autoimmune diseases, trials are testing increasing regulatory T-cells so the body is no longer being harmed. A similar approach could also be effective in reducing the chances of organ transplant failure.

Innovative Studies

Prof Shimon Sakaguchi, of Osaka University, conducted tests on rodents that had their immune gland extracted, causing self-attack conditions.

He demonstrated that introducing immune cells from healthy animals could stop the disease—implying there was a system for blocking immune cells from attacking the body.

Mary Brunkow, from the a research center in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were studying an inherited autoimmune disease in rodents and people that led to the discovery of a genetic factor vital for how regulatory T-cells operate.

"The pioneering research has revealed how the body's defenses is kept in check by T-reg cells, preventing it from accidentally attacking the body's own tissues," said a leading physiology expert.

"The work is a striking illustration of how basic biological study can have broad implications for human health."